Buparvaquone

Buparvaquone

SCHEMBL23064136

CC(C)(C)C1CCC(CC2=C(O)C(=O)c3ccccc3C2=O)CC1.NO

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.79
APAF1 O14727 2/20 0.39
TDP2 O95551 1/20 0.39
GLA P06280 1/20 0.35
POLB P06746 2/20 0.35
RAB9A P51151 2/20 0.35
ATM Q13315 2/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
DHODH Q02127 2/20 0.34
PABPC1 P11940 1/20 0.34
HPGD P15428 1/20 0.34
CSNK1A1 P48729 1/20 0.34
CSNK1D P48730 1/20 0.34
BLM P54132 1/20 0.34
MCL1 Q07820 1/20 0.34
PLEC Q15149 1/20 0.34
CSNK1G1 Q9HCP0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Buparvaquone SCHEMBL11030015 0.97 CDC25B (0.82) CDC25BAPAF1TDP2GLAPOLB
Buparvaquone SCHEMBL30634020 0.97 CDC25B (0.82) CDC25BAPAF1TDP2GLAPOLB
Buparvaquone SCHEMBL21863689 0.97 CDC25B (0.82) CDC25BAPAF1TDP2GLAPOLB
Buparvaquone SCHEMBL22978 0.97 CDC25B (0.82) CDC25BAPAF1TDP2GLAPOLB
Buparvaquone SCHEMBL9598809 0.97 CDC25B (0.82) CDC25BAPAF1TDP2GLAPOLB
Buparvaquone SCHEMBL18740425 0.91 CDC25B (0.73) CDC25BAPAF1TDP2GLAPOLB
SCHEMBL28771087 0.88 CDC25B (1.00) CDC25BAPAF1TDP2GLAPOLB
Buparvaquone SCHEMBL8200585 0.86 CDC25B (0.66) CDC25BAPAF1TDP2GLAPOLB
SCHEMBL11066448 0.86 CDC25B (0.65) CDC25BAPAF1TDP2POLBRAB9A
SCHEMBL11066443 0.86 CDC25B (0.65) CDC25BAPAF1TDP2POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130832-A1 METHODS OF GENE THERAPY OREGON HEALTH & SCIENCE UNIVERSITY 2021-05-06 US claimed
EP-3787693-A1 METHODS OF GENE THERAPY Oregon Health & Science University (US) 2021-03-10 EP claimed
US-20210130832-A1 METHODS OF GENE THERAPY OREGON HEALTH & SCIENCE UNIVERSITY 2021-05-06 US disclosed
EP-3787693-A1 METHODS OF GENE THERAPY Oregon Health & Science University (US) 2021-03-10 EP disclosed